[go: up one dir, main page]

UA104684C2 - Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты) - Google Patents

Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты)

Info

Publication number
UA104684C2
UA104684C2 UAA201300117A UAA201300117A UA104684C2 UA 104684 C2 UA104684 C2 UA 104684C2 UA A201300117 A UAA201300117 A UA A201300117A UA A201300117 A UAA201300117 A UA A201300117A UA 104684 C2 UA104684 C2 UA 104684C2
Authority
UA
Ukraine
Prior art keywords
agomelatine
intermediates
preparation
present
new intermediates
Prior art date
Application number
UAA201300117A
Other languages
English (en)
Ukrainian (uk)
Inventor
Пенг Жанг
Йу Хуанг
Жедонг Йуан
Ханбин Шан
Ксионг Йу
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45097542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA104684(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of UA104684C2 publication Critical patent/UA104684C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/06Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Battery Electrode And Active Subsutance (AREA)
UAA201300117A 2010-06-08 2011-06-08 Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты) UA104684C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2010101973700A CN102276492B (zh) 2010-06-08 2010-06-08 阿戈美拉汀中间体及其制备方法
PCT/CN2011/075438 WO2011153939A1 (en) 2010-06-08 2011-06-08 Agomelatine intermediates and preparation method thereof

Publications (1)

Publication Number Publication Date
UA104684C2 true UA104684C2 (ru) 2014-02-25

Family

ID=45097542

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201300117A UA104684C2 (ru) 2010-06-08 2011-06-08 Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты)

Country Status (41)

Country Link
US (1) US8779199B2 (ru)
EP (1) EP2580189B1 (ru)
JP (1) JP5519863B2 (ru)
KR (1) KR101470874B1 (ru)
CN (1) CN102276492B (ru)
AP (1) AP3205A (ru)
AU (1) AU2011264206B2 (ru)
BR (1) BR112012031086B1 (ru)
CA (1) CA2801822C (ru)
CL (1) CL2012003371A1 (ru)
CR (1) CR20120592A (ru)
CU (1) CU24148B1 (ru)
CY (1) CY1119857T1 (ru)
DK (1) DK2580189T3 (ru)
EA (1) EA020271B1 (ru)
EC (1) ECSP12012328A (ru)
ES (1) ES2656968T3 (ru)
GE (1) GEP20156234B (ru)
GT (1) GT201200328A (ru)
HR (1) HRP20171751T1 (ru)
HU (1) HUE035850T2 (ru)
IL (1) IL223180A (ru)
LT (1) LT2580189T (ru)
MA (1) MA34292B1 (ru)
ME (1) ME02992B (ru)
MX (1) MX2012013870A (ru)
MY (1) MY160954A (ru)
NI (1) NI201200177A (ru)
NO (1) NO2580189T3 (ru)
NZ (1) NZ604081A (ru)
PE (1) PE20130252A1 (ru)
PH (1) PH12012502275A1 (ru)
PL (1) PL2580189T3 (ru)
PT (1) PT2580189T (ru)
RS (1) RS56659B1 (ru)
SG (1) SG185667A1 (ru)
SI (1) SI2580189T1 (ru)
TN (1) TN2012000542A1 (ru)
UA (1) UA104684C2 (ru)
WO (1) WO2011153939A1 (ru)
ZA (1) ZA201208764B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
CN102452951B (zh) * 2010-10-25 2014-02-19 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
WO2014056421A1 (zh) * 2012-10-09 2014-04-17 江西同和药业有限责任公司 1-氰基-1-(7-甲氧基-1-萘基)甲醇酯类化合物及其制备方法和应用
CN112574066B (zh) * 2019-09-27 2024-10-25 江苏豪森药业集团有限公司 一种阿戈美拉汀中间体的制备方法
WO2021130057A1 (en) * 2019-12-23 2021-07-01 Dsm Ip Assets B.V. Dehydrogenation process

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
FR2866334B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
FR2866336B1 (fr) * 2004-02-13 2006-03-24 Servier Lab Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
WO2007147771A2 (en) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101486665B (zh) * 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法
EP2705023A4 (en) * 2011-01-04 2014-11-19 Symed Labs Ltd PROCESSES FOR THE PREPARATION OF N- [2- (7-METHOXY-1-NAPHTHYLLELYHYL) ACETAMIDE

Also Published As

Publication number Publication date
AP2013006659A0 (en) 2013-01-31
BR112012031086A2 (pt) 2017-06-20
HRP20171751T1 (hr) 2017-12-29
EA201201666A1 (ru) 2013-05-30
HUE035850T2 (en) 2018-05-28
NO2580189T3 (ru) 2018-03-24
GEP20156234B (en) 2015-01-26
CN102276492A (zh) 2011-12-14
LT2580189T (lt) 2017-12-11
GT201200328A (es) 2014-06-09
SI2580189T1 (en) 2018-01-31
CU20120163A7 (es) 2013-01-30
EP2580189A4 (en) 2016-01-06
CL2012003371A1 (es) 2013-03-22
DK2580189T3 (da) 2018-01-29
EP2580189B1 (en) 2017-10-25
CR20120592A (es) 2013-03-04
NZ604081A (en) 2014-01-31
CN102276492B (zh) 2013-04-10
PE20130252A1 (es) 2013-03-16
PH12012502275A1 (en) 2022-10-05
EP2580189A1 (en) 2013-04-17
CY1119857T1 (el) 2018-06-27
ECSP12012328A (es) 2012-12-28
AU2011264206B2 (en) 2013-08-15
AP3205A (en) 2015-03-31
IL223180A0 (en) 2013-02-03
ME02992B (me) 2018-10-20
CA2801822C (en) 2015-03-24
CA2801822A1 (en) 2011-12-15
ZA201208764B (en) 2014-01-29
PL2580189T3 (pl) 2018-04-30
JP5519863B2 (ja) 2014-06-11
JP2013531639A (ja) 2013-08-08
MY160954A (en) 2017-03-31
RS56659B1 (sr) 2018-03-30
TN2012000542A1 (en) 2014-04-01
AU2011264206A1 (en) 2012-12-13
MX2012013870A (es) 2013-01-24
US8779199B2 (en) 2014-07-15
PT2580189T (pt) 2017-12-06
US20130267738A1 (en) 2013-10-10
KR101470874B1 (ko) 2014-12-09
ES2656968T3 (es) 2018-03-01
BR112012031086B1 (pt) 2020-12-08
SG185667A1 (en) 2012-12-28
CU24148B1 (es) 2016-02-29
KR20130028134A (ko) 2013-03-18
MA34292B1 (fr) 2013-06-01
EA020271B1 (ru) 2014-09-30
WO2011153939A1 (en) 2011-12-15
IL223180A (en) 2014-06-30
NI201200177A (es) 2013-02-06

Similar Documents

Publication Publication Date Title
UA104684C2 (ru) Промежуточное соединение для получения агомелатина (варианты) и способ его получения (варианты)
WO2014043706A8 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
PH12015501258A1 (en) Methods of synthesizing a prostacyclin analog
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
DK2019114T3 (da) Fremgangsmåde til fremstilling af Drospirenon
IN2014DN07599A (ru)
WO2009153206A3 (en) Improved process for the production of bimatoprost
WO2011087316A3 (ko) 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
WO2013043009A3 (ko) 1-팔미토일-3-아세틸글리세롤의 제조방법 및 이를 이용한 1-팔미토일-2-리놀레오일-3-아세틸글리세롤의 제조방법
DK1797021T3 (da) Fremgangsmåder til fraseparering af modafinil
EA201391721A1 (ru) Способ получения полиморфной формы i эторикоксиба
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
JP5918624B2 (ja) 光学活性含フッ素5,6−ジヒドロピリドン誘導体及びその製造方法
WO2015188243A9 (en) PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
RU2550510C1 (ru) Способ получения этил(4е)-5-хлорпент-4-еноата
CO6592020A2 (es) Intemedios de agomelatina y método de preparación de éstos
MY147894A (en) Process for preparing intermediate compound for synthesizing an antiulcerant
BR112014029361A2 (pt) método de produção de ácido tereftálico e seus derivados
WO2012116817A3 (en) Process for producing highly purified n-propanol
TH133952A (th) สารมัธยันตร์อะโกเมลาทีน (Agomelatine intermediate) และ วิธีการเตรียมของสารนั้น
CN103880705B (zh) 二肟基紫罗兰酮及其制备方法和应用
CN105198796B (zh) 一种合成s‑1‑[(s)‑2‑(3,4,5‑三甲氧苯基)丁酰基]哌啶‑2‑羧酸的方法
CN104774160A (zh) 一种环丙基甲氰衍生物的制备方法
CN105541797A (zh) 盐酸巴尼地平的合成工艺
RU2515240C1 (ru) Способ получения 1-[(2е,4е)-дека-2,4-диеноил]пирролидина